CNSX:ORTH Ortho Regenerative Technologies (ORTH) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free ORTH Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2,500 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Ortho Regenerative Technologies alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. About Ortho Regenerative Technologies Stock (CNSX:ORTH)Ortho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.Read More Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. ORTH Stock News HeadlinesApril 26, 2024 | yahoo.comCambridge Bone & Joint mixes small-town feel and high-tech careApril 22, 2024 | finance.yahoo.comRising Prevalence of Orthopedic Disorders among Aging Population is Driving the Demand for Advanced Bone Screw Systems | Future Market Insights, Inc.April 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. April 16, 2024 | msn.comUnlocking the Transformative Potential of Bioactive Glass in HealthcareApril 12, 2024 | bizjournals.comTable of Experts: Advancements in orthopedic careMarch 27, 2024 | bizjournals.comDuke leads $33M federal project to forward osteoarthritis treatment, rebuild jointsMarch 27, 2024 | msn.comColumbia researchers secure $38.95 million ARPA-H contract to build a living knee replacementMarch 25, 2024 | msn.comORA announces new $50 million orthopedic campusApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 8, 2024 | msn.comHastings Orthopaedics looking to improve patient outcomes with new robot technologyFebruary 23, 2024 | finance.yahoo.comGlobal Biosurgery Market Size is Estimated to Reach USD 26,991.2 million by 2031, Growing at a CAGR of 6.87%: Straits ResearchFebruary 22, 2024 | msn.comNose cartilage-based knee joint treatment project receives €2.3 million fundingFebruary 14, 2024 | tmcnet.comTHINK Surgical to Collaborate with b-ONE Ortho Corporation for Robotic TKAFebruary 12, 2024 | finance.yahoo.comGlobal Cruciate Ligament Repair Procedures Market Analysis & Forecast 2024-2034: Market Forecast to Surge to $28.95 Billion by 2034February 9, 2024 | finance.yahoo.comAmniotic Membrane Market is Projected to Surpass USD 5.2 billion by 2031, Growing at CAGR 9.9%- Report by Transparency Market Research, Inc.February 6, 2024 | finanznachrichten.deFibroBiologics Announces Three Japanese Patents on Fibroblast TechnologyFebruary 1, 2024 | finance.yahoo.comKuros Biosciences to Present at the CG 2024 Musculoskeletal ConferenceJanuary 29, 2024 | msn.comNew ROSA robot to help orthopedic surgery at Augusta HealthJanuary 22, 2024 | uk.finance.yahoo.comOrthopedic Devices Sector Forecast: In-Depth Analysis of the Cartilage Repair Market Growth, Regulatory Framework, and Projections Through 2033January 16, 2024 | finance.yahoo.comGuided Bone Regeneration Market Value to cross US$ 1.2 billion Mark by 2034|Fact.MR ReportJanuary 15, 2024 | au.investing.comOrthocell board renewal to focus on balance sheet and commercialisationJanuary 9, 2024 | finance.yahoo.comGlobal Polymeric Biomaterials Market Projected to Reach USD 148.87 Billion by 2030—Driven by Rising Demand for Regenerative Medicine TreatmentsJanuary 8, 2024 | uk.finance.yahoo.comGlobal Cartilage Repair/Cartilage Regeneration Market Forecasts to 2028 - Rising Number of Sports and Accident-Related Orthopedic InjuriesJanuary 3, 2024 | ca.finance.yahoo.comCHITOGENX REPORTS THIRD QUARTER 2024 RESULTSJanuary 2, 2024 | finance.yahoo.comCGBio's 'NOVOSIS PUTTY' Receives FDA 'Breakthrough Device Designation,' Accelerate Entry into the US MarketDecember 27, 2023 | businesswire.comAdvanced Orthopedic Technologies, Implants and Regenerative Products Market Outlook Report to 2027 - A $84.8 Billion Market by 2027 - ResearchAndMarkets.comDecember 19, 2023 | finance.yahoo.com4 Orthobiologic Stocks Set To Soar In 2024See More Headlines Receive ORTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ortho Regenerative Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolCNSX:ORTH CUSIPN/A CIKN/A Webwww.orthorti.com Phone+1-514-7820951FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Brent Henry Barry NortonPres & Chief Exec. OfficerMr. Luc Mainville M.B.A (Age 55)Sr. VP & CFO Prof. Michael Buschmann (Age 57)Chief Scientific Officer, Corp. Sec. & Director Benedek SimoControllerKey CompetitorsAscent Solar TechnologiesCNSX:ASTICannabix TechnologiesCNSX:BLO45525 (CUR.TO)TSE:CURAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAView All Competitors ORTH Stock Analysis - Frequently Asked Questions How do I buy shares of Ortho Regenerative Technologies? Shares of ORTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:ORTH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ortho Regenerative Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
